Inactive Instrument

Other languages Zosano Pharma Corp Nasdaq

Equities

US98979H1032

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Zosano Pharma Corporation Went Out of Business	22-12-06
Disclosure Statement Approved for Zosano Pharma Corporation	22-10-07
First Motion for Exclusivity Period Extension Filed by Zosano Pharma Corporation	22-09-21
Emergex USA Corporation completed the acquisition of Substantially all assets of Zosano Pharma Corporation for $1 million.	22-08-24
Motion for Case Conversion Filed for Zosano Pharma Corporation	22-06-22
Zosano Pharma Files for Chapter 11 Bankruptcy	22-06-02
Zosano Pharma Plans to Sell Assets	22-06-01
Zosano Pharma Corporation Filed for Bankruptcy	22-06-01
MÄRKTE USA/Zurückhaltung dominiert an der Wall Street	22-05-16
MÄRKTE USA/Wall Street neigt schon wieder zur Schwäche	22-05-16
MÄRKTE USA/Wall Street dürfte schon wieder zur Schwäche neigen	22-05-16
Zosano Pharma Tumbles After-Hours on Going Concern Warning, Higher Q1 Loss	22-05-13
Joseph “Jay” P. Hagan Resigns as Director of the Board of Directors of Zosano Pharma Corporation	22-05-13
Zosano Pharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13
Steven A. Elms Tenders His Resignation as Director of the Board of Directors of Zosano Pharma Corporation	22-05-05
Zosano Pharma Suspends M207 Program, Explores Strategic Alternatives	22-04-29
Zosano Pharma Exploring Financial and Strategic Alternatives to Maximize Value	22-04-28
Zosano Pharma Board Approves One-for-35 Reverse Stock Split	22-04-11
Zosano Pharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-17
Zosano Pharma Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-03-17

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Zosano Pharma Corp Nasdaq

Equities

US98979H1032

Other languages

Filters